Stock TitanGlobal Clinical Trial Launches: New Device Targets 435,000 Annual Pulmonary Embolism Cases2 days agoMore
GuruFocusAngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F18?? System for Treatment of Acute Pulmonary Embolism | ANGO Stock News2 days agoMore
Full CoverageFull Coverage